Table 3.
Capability list for neonatal critical care centre of city level and the importance scores
| City-level capability items | Round 1 | Round 2 | ||||||
| Mean* | SD* | N† | %† | Mean* | SD* | N† | %† | |
| Domain 1: clinical technique | ||||||||
| Neonatal resuscitation | 5.00 | 0.00 | 20 | 100.0 | 5.00 | 0.00 | 20 | 100.0 |
| Endotracheal intubation | 5.00 | 0.00 | 20 | 100.0 | 5.00 | 0.00 | 20 | 100.0 |
| Oxygen therapy | 4.85 | 0.49 | 19 | 95.0 | 4.85 | 0.49 | 19 | 95.0 |
| Continuous positive airway pressure | 4.90 | 0.45 | 19 | 95.0 | 4.90 | 0.45 | 19 | 95.0 |
| Conventional ventilation | 5.00 | 0.00 | 20 | 100.0 | 5.00 | 0.00 | 20 | 100.0 |
| Surfactant administration | 4.95 | 0.22 | 20 | 100.0 | 4.95 | 0.22 | 20 | 100.0 |
| (Round 1) Chest drainage; (round 2, revised and included) Thoracocentesis and/or chest drainage | 4.90 | 0.31 | 20 | 100.0 | 5.00 | 0.00 | 20 | 100.0 |
| (Round 2, added and included) Lumbar puncture | – | – | – | – | 5.00 | 0.00 | 20 | 100.0 |
| (Round 2, added and included) Abdominocentesis | – | – | – | – | 5.00 | 0.00 | 20 | 100.0 |
| (Round 2, added and included) Bone marrow aspiration | – | – | – | – | 4.05 | 0.51 | 18 | 90.0 |
| Intravenous cannula insertion | 4.85 | 0.37 | 20 | 100.0 | 4.85 | 0.37 | 20 | 100.0 |
| Umbilical arterial and venous catheters | 5.00 | 0.00 | 20 | 100.0 | 5.00 | 0.00 | 20 | 100.0 |
| (Round 1) Peripheral vein catheterisation; (round 2, revised and included) Peripherally inserted central catheters | 4.90 | 0.31 | 20 | 100.0 | 5.00 | 0.00 | 20 | 100.0 |
| Exchange transfusion | 5.00 | 0.00 | 20 | 100.0 | 5.00 | 0.00 | 20 | 100.0 |
| (Round 1) An on-site blood bank; (round 2, revised and included) Blood transfusion | 4.75 | 0.44 | 20 | 100.0 | 4.95 | 0.22 | 20 | 100.0 |
| Non-invasive physiological monitoring | 5.00 | 0.00 | 20 | 100.0 | 5.00 | 0.00 | 20 | 100.0 |
| Phototherapy | 4.90 | 0.31 | 20 | 100.0 | 4.90 | 0.31 | 20 | 100.0 |
| Total parenteral nutrition | 4.95 | 0.22 | 20 | 100.0 | 4.95 | 0.22 | 20 | 100.0 |
| (Round 2, added and included) Enteral nutrition | – | – | – | – | 4.95 | 0.22 | 20 | 100.0 |
| Rehabilitative care | 4.00 | 0.46 | 18 | 90.0 | 4.00 | 0.46 | 18 | 90.0 |
| Medical care for severe sepsis and multiple system organ failure | 4.95 | 0.22 | 20 | 100.0 | 4.95 | 0.22 | 20 | 100.0 |
| Domain 2: laboratory and imaging tests | ||||||||
| Mobile ultrasound scanning | 4.80 | 0.41 | 20 | 100.0 | 4.80 | 0.41 | 20 | 100.0 |
| Mobile X-ray | 4.85 | 0.37 | 20 | 100.0 | 4.85 | 0.37 | 20 | 100.0 |
| (Round 2, added and included) 24-hour blood gas analysis | – | – | – | – | 5.00 | 0.00 | 20 | 100.0 |
| CT | 4.05 | 0.39 | 19 | 95.0 | 4.05 | 0.39 | 19 | 95.0 |
| Hearing screening | 4.90 | 0.31 | 20 | 100.0 | 4.90 | 0.31 | 20 | 100.0 |
| Screening for retinopathy of prematurity | 4.85 | 0.37 | 20 | 100.0 | 4.85 | 0.37 | 20 | 100.0 |
| Test for haemolytic disease | 4.95 | 0.22 | 20 | 100.0 | 4.95 | 0.22 | 20 | 100.0 |
| Biochemical test | 4.95 | 0.22 | 20 | 100.0 | 4.95 | 0.22 | 20 | 100.0 |
| Aetiological diagnosis (eg, bacteria, fungus, TORCH) | 5.00 | 0.00 | 20 | 100.0 | 5.00 | 0.00 | 20 | 100.0 |
| Immunological test | 4.05 | 0.51 | 18 | 90.0 | 4.05 | 0.51 | 18 | 90.0 |
| Cytological examination | 4.00 | 0.46 | 18 | 90.0 | 4.00 | 0.46 | 18 | 90.0 |
| Pathological examination | 4.05 | 0.39 | 19 | 95.0 | 4.05 | 0.39 | 19 | 95.0 |
| Chromosome examination | 4.00 | 0.46 | 18 | 90.0 | 4.00 | 0.46 | 18 | 90.0 |
| Domain 3: management measures for inpatient newborns | ||||||||
| Paediatric critical illness score | 5.00 | 0.00 | 20 | 100.0 | 5.00 | 0.00 | 20 | 100.0 |
| Follow-up after discharge | 4.90 | 0.31 | 20 | 100.0 | 4.90 | 0.31 | 20 | 100.0 |
| 24-hour neonatal transport service | 4.75 | 0.55 | 19 | 95.0 | 4.75 | 0.55 | 19 | 95.0 |
| Medical care for newborns born ≥28 weeks’ gestation or weighing ≥1000 g | 4.95 | 0.22 | 20 | 100.0 | 4.95 | 0.22 | 20 | 100.0 |
*Mean and SD of 5-point Likert scores (1=very unimportant; 2=unimportant; 3=neutral; 4=important and 5=very important).
†Number and percentage of experts who rated 4 (important) or 5 (very important).
TORCH, Toxoplasma gondii, Rubella virus, Cytomegalovirus, Herpes simplex viruses, and other agents.